| No Malfunction As Prince Rocks Halftime
Phew! CBS got through the halftime show without a "wardrobe malfunction." The Artist Formerly Known as a Munchkin of Wardrobe Dysfunction began by singing "Let's Go Crazy," but he didn't.
Prince, who became a Jehovah's Witness in the mid-1990s, no longer wears yellow, butt-baring pants as he did at the 1991 MTV Video Music Awards (prompting Howard Stern's send-up at the '92 VMAs). The closest thing to a fashion statement Sunday night was an odd kerchief on his head. So the NFL had no repeat of the 2004 Janet Jackson/Justin Timberlake show, which happened the last time CBS broadcast the game.
The 48-year-old Prince, who rose to stardom in the '80s with his distinctive fusion of R&B, funk, soul and rock, once looked androgynous and produced songs that (lest we forget) drove Tipper Gore nuts (and made her a fat target for anti-censorship types like Frank Zappa).
Esophageal cancer: it
STOCKTON SPRINGS — When Connie Corrigan tapped out an e-mail message to Gov. John Baldacci last July, the Stockton Springs woman was still so infuriated about her husband's death four months earlier, she said, “that I wrote it and just hit ‘send.' I didn't even spell-check it." .
Schering-Plough Fourth Quarter Earnings Call
This summary is based on the fourth quarter fiscal 2006 earnings call conducted by Schering-Plough Corp. (SGP: chart) on January 29, 2007. Key Investors Issues - Earnings per share were 12 cents compared to 7 cents in the year ago quarter. - Quarterly revenue grew 14% over the prior year to $2.7 billion. - Schering-Ploughs cholesterol joint venture with Merck reported revenue of $1.1 billion versus $755 million in prior year. Fourth Quarter Fiscal 2006 Financial Highlights For the quarter, the company reported net income available to common shareholders of $182 million or 12 cents per share on a GAAP basis. This included an unfavorable impact of 4 cents per share related to the actions during 2006 to streamline the company''s manufacturing operations and a charge of 1 cent per share related to the licensing of an over-the-counter (OTC) treatment for heartburn.
(AFX UK Focus) 2007-01-30 23:59 GMT: Merck, Wyeth shares fall after reports
TRENTON, N.J. (AFX) - Shares of drug makers Wyeth and Merck & Co. took a hit Tuesday after disappointing earnings reports, but for different reasons: Wyeth missed analysts' expectations by a wide margin, while Merck's profit plunged due to ongoing legal and restructuring costs. Merck surprised some analysts by boosting its reserve for litigation over withdrawn painkiller Vioxx for a second straight quarter. That charge and others cut Merck's fourth-quarter profit by 58 percent despite higher revenues. Shares fell 60 cents, or 1.6 percent, to $44.91 with nearly double normal trading volume. Wyeth shares fell $1.24, or 2.5 percent, to $49.36, also on the New York Stock Exchange, as the Madison, N.J.-based company boosted quarterly profit by 17 percent but came in a nickel below analysts' consensus of 71 cents in earnings per share.
|
